Media Coverage

Using microbial community-scale metabolic models, ISB’s Gibbons Lab can analyze an individual’s gut microbiome data and predict the colonization risk of Clostridioides difficile. In an interview, Associate Professor Dr. Sean Gibbons discussed the implications of this research.

This news story details work out of ISB’s Gibbons Lab – the developtment of personalized modeling framework that forecasts C. diff colonization risk based on an individual’s unique gut microbiome. The team demonstrated how these models can also test targeted probiotic therapies designed to suppress C. diff growth before it turns deadly.

Published research out of ISB’s Gibbons Lab is highlighted in this story, showing that pooping too often or too rarely are both associated with different underlying health issues.

How does food DNA impact the human body? In what ways do ecological communities in the gut change and adapt to individual people over time? In this podcast episode, Dr. Sean Gibbons discusses a breakthrough method that analyzes food-derived DNA in fecal metagenomes – and what this means for human health.

In this deep-dive episode, Matt Kaberlein sits down with Sean Gibbons, one of the leading researchers in human microbiome science, to explore the complexity, nuance, and emerging applications of gut microbiome research. They cover both foundational and cutting-edge topics.

In this hour-long video interview, Sui Huang discusses his paradigm-changing ideas for how we understand cancer and how they can influence how the disease is treated.

Sean Gibbons spoke with Science Focus about the link between the frequency of bowel movements and long-term health.

Infrequent pooping may be setting yourself up for medical problems down the road, and pooping too often brings its own issues. Research out of the Gibbons Lab details the “Goldilocks” zone.